Jay Rajagopalan from PSG Biotech’s Malema division discussed the evolving impact of industry trends on sensor technologies at INTERPHEX 2024. He highlighted FDA’s PAT initiatives and the shift to real-time measurement and multi-parameter sensing. Innovations like single-use technologies and Coriolis flow meters were emphasized, along with the vital role of digitalization in enhancing data quality and predictive maintenance.
At INTERPHEX 2024, Jay Rajagopalan, senior director for Engineering & Product Management at PSG Biotech’s Malema division, illuminated the significant impact of evolving industry trends on sensor technologies in the bio/pharmaceutical sector. The dialogue highlighted how the FDA’s push for process analytical technology (PAT) has transformed practices, enabling real-time flow measurement. This move marks a shift from traditional sampling methods to a dynamic, in-situ approach, enhancing compliance and streamlining processes.
Rajagopalan made a compelling case for the trend toward multi-parameter sensing, where intricate sensors capture various data points simultaneously. For instance, integrating pressure and temperature metrics with flow measurements creates a richer data tapestry that supports real-time decision-making. He emphasized that innovations like single-use technologies and Coriolis mass flow meters, which excel in high-purity environments, represent significant advancements in sensor capabilities, ensuring accurate readings regardless of fluctuating conditions.
Delving into digitalization, Rajagopalan discussed how modern sensors have evolved from their analog predecessors. These digital marvels can transmit a plethora of data regarding process conditions, sensor health, and product integrity through unified communication channels. This abundance of information empowers customers, leading to enhanced predictive maintenance practices and fostering a culture where data-driven decisions reign supreme.
The discussion revolves around the burgeoning intersection of sensor technologies and the bio/pharmaceutical industry’s shifting landscape. Rapid advancements necessitated by regulations and technological improvements are driving the evolution of sensor systems from simple analog devices to sophisticated digital units capable of delivering multifaceted data in real-time. This evolution is vital for maintaining product integrity and ensuring compliance with stringent industry standards.
The insights from Rajagopalan at INTERPHEX 2024 paint a vibrant picture of a bio/pharmaceutical landscape rapidly embracing technological advancements in sensor systems. With a focus on real-time measurement, multi-parameter sensing, and digitalization, the industry stands on the precipice of a transformative era, where data-driven insights lead to improved efficiency, compliance, and reduced risks. As these sensor technologies continue to evolve, they promise to play an integral role in the future of bio/pharma operations.
Original Source: www.pharmtech.com
